Get started
RocketTickers

Altimmune Announces Positive Results From 12-week Phase 1 Clinic

Long
Altimmune, Inc. (NASDAQ:ALT)  
RocketTickers  
NASDAQ:ALT   Altimmune, Inc.
Beyond Technical Analysis
1
0
beyondta
ALT: Altimmune, Inc
2021-09-28 07:01:00
Altimmune Announces Positive Results From 12-week Phase 1 Clinical Trial of ALT-801 (Pemvidutide) in Overweight and Obese Volunteers
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.